Serina Therapeutics Inc (SER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 7,375 |
| Receivables | 0 | 0 | 0 | 107 |
| Other current assets | 0 | 0 | 0 | 111 |
| TOTAL | $0 | $0 | $0 | $7,593 |
| Non-Current Assets | ||||
| PPE Net | N/A | N/A | N/A | 274 |
| Other Non-Current Assets | 0 | 0 | 0 | 1,909 |
| TOTAL | $N/A | $N/A | $N/A | $2,183 |
| Total Assets | $0 | $0 | $0 | $9,631 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 768 |
| Other current liabilities | 0 | 0 | 0 | 544 |
| TOTAL | $0 | $0 | $0 | $1,312 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 34 | 21 | 86 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $0 | $0 | $0 | $1,312 |
| Shareholders' Equity | ||||
| Common Shares | 0 | 0 | 0 | 3 |
| Retained earnings | 0 | 0 | 0 | -66,552 |
| Other shareholders' equity | 0 | 0 | 0 | 1,107 |
| TOTAL | $0 | $0 | $0 | $8,319 |
| Total Liabilities And Equity | $0 | $0 | $0 | $9,631 |